Curaleaf Holdings (CURLF) Preferred Stock Liabilities (2024)
Curaleaf Holdings (CURLF) posted quarterly Preferred Stock Liabilities of $9.4 million for Q3 2024.
Curaleaf Holdings (CURLF) Preferred Stock Liabilities (2024) Analysis & Trends
Curaleaf Holdings' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $9.4 million for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.11 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.27 Bn | 39.61 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.81 Bn | 30.14 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 9.37 Mn |